Article
Genetics and molecular biology of chronic lymphocytic leukemia.
Current treatment options in oncology - 1 May 2005
Carney Dennis A, Wierda William G
Abstract excerpt
B cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease characterized by accumulation of malignant CD5+ B cells. Multiple molecular events likely contribute to malignant transformation; no single genetic abnormality or event has been shown to be responsible for development of the disease. Significant advances have recently been made towards understanding the genetic and molecular basis for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
